We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.1B
1-Year Est. Return 4.68%
This Fund
S&P 500
This Quarter Est. Return
-0.02%
1 Year Est. Return
+4.68%
3 Year Est. Return
+8.24%
5 Year Est. Return
+32.95%
10 Year Est. Return
AUM
$1.4B
AUM Growth
-$180M
Cap. Flow
-$842M
Cap. Flow %
-59.91%
Top 10 Hldgs %
35.82%
Holding
285
New
71
Increased
30
Reduced
16
Closed
59

Sector Composition

Rank Sector Weight
1 Financials 5.56%
2 Technology 4.91%
3 Communication Services 3.05%
4 Industrials 2.27%
5 Healthcare 1.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PATK icon
76
PUT
Patrick Industries
PATK
$2.92B
$1.29M 0.09%
+37,500
New +$1.48M
KRTX
77
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.26M 0.09%
+10,000
New +$1.15M
KRTX
78
PUT
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.26M 0.09%
+10,000
New +$1.15M
UAA icon
79
Under Armour
UAA
$3.17B
$1.25M 0.09%
150,000
+50,000
+50% +$613K
CVET
80
DELISTED
Covetrus, Inc. Common Stock
CVET
$1.19M 0.08%
+57,409
New +$1.02M
TWTR
81
PUT
DELISTED
Twitter, Inc.
TWTR
$1.12M 0.08%
+30,000
New +$1.29M
JBTM
82
PUT
JBT Marel
JBTM
$6.98B
$1.1M 0.08%
+10,000
New +$1.15M
BILL icon
83
PUT
BILL Holdings
BILL
$4.45B
$1.1M 0.08%
+10,000
New +$1.46M
MNDT
84
DELISTED
Mandiant, Inc. Common Stock
MNDT
$1.09M 0.08%
50,000
ATCO
85
PUT
DELISTED
Atlas Corp.
ATCO
$1.07M 0.08%
100,000
-181,000
-64% -$2.27M
UPWK icon
86
PUT
Upwork
UPWK
$1.12B
$1.03M 0.07%
+50,000
New +$983K
BMRN icon
87
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.01M 0.07%
+12,200
New +$971K
HOUS
88
PUT
DELISTED
Anywhere Real Estate
HOUS
$982K 0.07%
100,000
-210,000
-68% -$2.47M
CLDX icon
89
Celldex Therapeutics
CLDX
$2.77B
$971K 0.07%
36,000
+28,300
+368% +$822K
CLDX icon
90
PUT
Celldex Therapeutics
CLDX
$2.77B
$971K 0.07%
+36,000
New +$1.05M
AMRS
91
PUT
DELISTED
Amyris Inc.
AMRS
$956K 0.07%
515,000
-1,303,700
-72% -$3.84M
UPWK icon
92
Upwork
UPWK
$1.12B
$943K 0.07%
+45,600
New +$896K
CFRX
93
PUT
DELISTED
ContraFect Corporation
CFRX
$931K 0.07%
+3,829
New +$1.08M
MDRX
94
PUT
DELISTED
Veradigm Inc. Common Stock
MDRX
$890K 0.06%
+60,000
New +$1.12M
PLRX icon
95
CALL
Pliant Therapeutics
PLRX
$71.2M
$881K 0.06%
+110,000
New +$704K
BKNG icon
96
CALL
Booking.com
BKNG
$141B
$875K 0.06%
12,500
KCGI
97
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
$855K 0.06%
86,500
BMRN icon
98
PUT
BioMarin Pharmaceuticals
BMRN
$11.5B
$829K 0.06%
+10,000
New +$796K
CNX icon
99
PUT
CNX Resources
CNX
$4.71B
$823K 0.06%
+50,000
New +$1.02M
TVTX icon
100
CALL
Travere Therapeutics
TVTX
$5.27B
$793K 0.06%
+32,700
New +$822K

Similar funds

DLD Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, DLD Asset Management held 285 positions worth $1.4B, down 11% from $1.58B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

DLD Asset Management withdrew a net $842M in Q2 2022, closing 59 positions and reducing 16 holdings. Its most notable exit was Mimecast Limited, an estimated $13.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 5.6% of assets, down from 5.8% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DLD Asset Management opened a new position in American Campus Communities, Inc. worth $19.3M.

  • DLD Asset Management's largest Q2 2022 buy was American Campus Communities, Inc.: 300,000 shares worth $19.3M.
  • DLD Asset Management added most to Plantronics, Inc. in Q2 2022, an estimated $5.16M increase.
  • DLD Asset Management's biggest Q2 2022 reduction was Healthcare Realty, cutting an estimated $4.68M.
  • DLD Asset Management fully exited Mimecast Limited in Q2 2022, selling an estimated $13.5M.
  • DLD Asset Management's ten largest holdings make up 36% of its $1.4B portfolio in Q2 2022.
  • DLD Asset Management opened 71 new positions and closed 59 in Q2 2022.
  • DLD Asset Management's portfolio value fell 11% quarter-over-quarter to $1.4B.

Based on DLD Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.